Bayer to now sell BIVI CYDECTIN in U.S.

· December 7, 2016

Bayer has expanded their animal health product portfolio, with a recent agreement with Boehringer Ingelheim Vetmedica, Inc. (BIVI)  to acquire BIVI’s CYDECTIN bovine and ovine endectocide products in the U.S. Once completed, the deal would include the transfer of CYDECTIN Pour-On, CYDECTIN Injectable, and CYDECTIN Oral Drench. These endectocides with the active ingredient moxidectin offer […]

Load more